Publication: 2241

Publication: 2241

The relationship between quantitative human epidermal growth factor receptor 2 gene expression by the 21-gene reverse transcriptase polymerase chain reaction assay and adjuvant trastuzumab benefit in Alliance N9831

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Breast Cancer Res vol 17

Year:: 2015
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: Accepted

Note:: 2238 is parent abstract. Also supported by the Breast Cancer Research Foundation and Genentech (35-03)

Methodological:: No
Biospecimen:: Yes
SDC:: Yes
Book Volume:: 5

Parents:: 963
Children:: None

Program:: OGC
Primary Committee:: Breast
Sec. Committees:

Pharmas:
Grants:: U24CA196171 , U10 CA180821, P50 CA121973, U10-CA025224, P30 CA023108, U10-CA180821, U10 CA180882, U24 CA196171, R01 CA129949, U10-CA180882, U10 CA025224, U10 CA180844

Corr. Author:
Authors:: Edith A. Perez Frederick L. Baehner Steven M. Butler E. Aubrey Thompson Amylou C. Dueck Farid Jamshidian Diana Cherbavaz Carl Yoshizawa Steven Shak Peter A. Kaufman Nancy E. Davidson Julie Gralow Yan W. Asmann Karla V. Ballman

Networks:: LAPS-MN026, PR028, VT004

Study: NCCTG-N9831
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords:: Research Article